Published

STERIS’s (STE) Overweight Rating Reiterated at Stephens

Summary by modernreaders.com
Stephens restated their overweight rating on shares of STERIS (NYSE:STE – Free Report) in a research report report published on Thursday morning,Benzinga reports. Stephens currently has a $260.00 price objective on the medical equipment provider’s stock. A number of other analysts have also recently weighed in on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Thursday, August 8th. StockN…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)